Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    WS07 - LATAM Workshop

    • 15:00 - 16:30
    • 8/06/2022
    • Location: Lehar 2
    • Not for CME Credit
    • Type: Workshop
    • Track: N/A
    • +

      WS07.08 - Ancestry and Somatic Mutations in Lung Cancer in Latin America

      15:52 - 16:02  |  Presenter: Ticiana Leal

      • Abstract

      Loading...

  • +

    EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      EP08.02-019 - Phase 1/2 Study of BLU-701, a Highly Selective EGFR Inhibitor, in Patients With EGFR-Mutant Non-Small Cell Lung Cancer

      Presenter: Alexander Spira

      • Abstract

      Loading...

  • +

    EP14.03 - Small Cell Lung Cancer and Neuro-endocrine Tumors - RT

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - RT
    • +

      EP14.03-003 - Phase I Study of Palliative Radiotherapy with Lurbinectedin in Patients with Extensive Stage Small Cell Lung Cancer

      Presenter: Neal Sean Mccall

      • Abstract

      Loading...

  • +

    P1.10 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
    • +

      P1.10-04 - Impact of Radiation Dose to the Immune Cells in Unresectable or Stage III Non-Small Cell Lung Cancer in the Durvalumab Era

      Presenter: Neal Sean Mccall

      • Abstract

      Loading...

  • +

    MA06 - Resectable and Unresectable Locally Advanced Lung Cancer

    • 12:15 - 13:15
    • 8/08/2022
    • Location: Lehar 1
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Locally Advanced Non-small Cell Lung Cancer
    • +

      MA06.05 - Consolidation Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation for Patients with Unresectable Stage III NSCLC

      12:27 - 12:32  |  Presenter: Greg Andrew Durm

      • Abstract

      Loading...

  • +

    P2.02 - Metastatic Non-small Cell Lung Cancer - Palliative Chemotherapy

    • 17:15 - 19:15
    • 8/08/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Palliative Chemotherapy
    • +

      P2.02-02 - A Phase 2 Study of MLN4924 (Pevonedistat) in Combination with Carboplatin and Paclitaxel in Advanced NSCLC Previously Treated with Immunotherapy

      Presenter: Ralph Linwood Millett

      • Abstract

      Loading...

  • +

    P2.04 - Nursing and Allied Health Professionals

    • 17:15 - 19:15
    • 8/08/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Nursing and Allied Health Professionals
    • +

      P2.04-05 - Is Opioid Use in the Management of Stage III Non-Small Cell Lung Cancer Patients Necessary?

      Presenter: Ulrike Gorgens

      • Abstract

      Loading...

  • +

    OA15 - Patient Selection in Advanced NSCLC Immunotherapy

    • 14:30 - 15:30
    • 8/09/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • +

      OA15.06 - Pooled Analysis of Outcomes With Second-Course Pembrolizumab Across 5 Phase 3 Studies of Non-Small-Cell Lung Cancer

      15:02 - 15:12  |  Presenter: Delvys Rodriguez-Abreu

      • Abstract

      Loading...